Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Her2 Positive Metastatic Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00146549
What this trial is testing

Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer

Who this might be right for
Breast CancerStage IV Breast Cancer
Dana-Farber Cancer Institute 250
Testing effectiveness (Phase 2)Study completedNCT01042925
What this trial is testing

Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based Regimen

Who this might be right for
Breast CancerBreast Neoplasms
Sanofi 42
Testing effectiveness (Phase 2)Study completedNCT01622868
What this trial is testing

Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer

Who this might be right for
HER2-Positive Breast CarcinomaInvasive Breast CarcinomaMetastatic Malignant Neoplasm in the Brain+2 more
National Cancer Institute (NCI) 143
Not applicableActive Not RecruitingNCT07493291
What this trial is testing

Effectiveness and Safety of Palbociclib: Brand vs. Generic in Iraqi Stage IV Breast Cancer Patients

Who this might be right for
Brest CancerCDK4/6 Inhibitor
Al-Mustansiriyah University 100
Testing effectiveness (Phase 2)Looking for participantsNCT07164976
What this trial is testing

Ribociclib for HR-positive HER2-negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Nagoya City University 86
Not applicableEnrolling By InvitationNCT06821490
What this trial is testing

Validation of TAD in HER-2 with More Than 2 Lymph Nodes

Who this might be right for
Breast Carcinoma Metastatic in Lymph NodeHER2 Positive Breast Carcinoma
Fundación para la Investigación del Hospital Clínico de Valencia 21
Post-approval studies (Phase 4)Not Yet RecruitingNCT06245824
What this trial is testing

Trastuzumab Deruxtecan (T-DXd) With Pyrotinib in First-line HER2-positive Unresectable or Metastatic Breast Cancer Trial

Who this might be right for
Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 51
Testing effectiveness (Phase 2)Ended earlyNCT03566485
What this trial is testing

Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer

Who this might be right for
Stage III Breast CancerStage IIIA Breast CancerStage IIIB Breast Cancer+4 more
Vanderbilt-Ingram Cancer Center 12
Early research (Phase 1)Study completedNCT01816035
What this trial is testing

Trastuzumab Emtansine in Treating Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed by Surgery

Who this might be right for
HER2/Neu PositiveRecurrent Breast CarcinomaStage IIIB Breast Cancer+2 more
University of Washington 13
Large-scale testing (Phase 3)Not Yet RecruitingNCT07366840
What this trial is testing

RC48 Combined With Chemotherapy in HER2-Positive Advanced Breast Cancer Patients With Prior TOP1i-ADC Failure

Who this might be right for
HER2-positive Breast CancerMetastatic Breast Cancer
Fudan University 268
Not applicableNot Yet RecruitingNCT06015113
What this trial is testing

Efficacy and Safety of Disitamab Vedotin Plus Pyrotinib or Naratinib in HER2-positive Breast Cancer Patients With Brain Metastasis

Who this might be right for
Breast Cancer
Xi'an International Medical Center Hospital 20
Not applicableStudy completedNCT04566458
What this trial is testing

RWD Study in HER2+ mBC Patients in Third-Line Therapy

Who this might be right for
Breast Cancer Stage IV
Exactis Innovation 63
Not applicableEnded earlyNCT01712815
What this trial is testing

PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer

Who this might be right for
HER2-positive Breast CancerRecurrent Breast CancerStage IA Breast Cancer+6 more
University of Southern California 12
Early research (Phase 1)Study completedNCT01009437
What this trial is testing

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
Masonic Cancer Center, University of Minnesota 28
Large-scale testing (Phase 3)Study completedNCT02492711
What this trial is testing

Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer

Who this might be right for
HER-2 Positive Breast CancerMetastatic Neoplasm
MacroGenics 624
Early research (Phase 1)Looking for participantsNCT06251544
What this trial is testing

TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer

Who this might be right for
Breast CancerTumor, BreastBreast Tumor+5 more
Baylor College of Medicine 27
Not applicableNot Yet RecruitingNCT06882499
What this trial is testing

Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II

Who this might be right for
Breast Cancer, MetastaticMetastatic Breast Cancer
Peter MacCallum Cancer Centre, Australia 74
Not applicableLooking for participantsNCT07166185
What this trial is testing

Efficacy of Neoadjuvant Subcutaneous Trastuzumab-Pertuzumab in Algerian Women With Locally Advanced HER2 Positive Breast Cancer

Who this might be right for
Non Metastatic HER2 Positive Breast Cancer
Blida 1 University 70
Not applicableUnknownNCT04247035
What this trial is testing

Τreatment Standards and Outcomes of Patients With ER/PR Positive, HER2-negative Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Hellenic Society of Medical Oncology 300
Testing effectiveness (Phase 2)UnknownNCT00431704
What this trial is testing

VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast Cancer

Who this might be right for
Metastatic Breast Cancer
National Cancer Institute, Naples 39
Next Page